🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label fixed dose phase Ib of anti-CEA CAR-T cells hepatic a...
Status
Completed
Location
Roger Williams Medical Center
Start Date
2015-04
Trial ID
NCT02416466
Treatments Being Tested
This study is an open-label, single arm phase 1b safety study of CAR2 Anti-...
Status
Terminated
Location
Roger Williams Medical Center
Start Date
2019-07-29
Trial ID
NCT03818165
Treatments Being Tested
This is a single-center, open-label clinical study of anti-CEA-CAR-T cells ...
Status
Recruiting
Location
The First Affiliated Hospital of China Medical Univeristy
Start Date
2023-10-23
Trial ID
NCT06013111
Treatments Being Tested
The main purpose of this research is to verify the safety of CEA targeted c...
Status
Unknown
Location
Southwest Hospital of Third Millitary Medical University
Start Date
2014-12
Trial ID
NCT02349724
Treatments Being Tested
This is a phase I clinical study to evaluate the safety and tolerability of...
Status
Completed
Location
First affiliated hospital, Zhejiang University
Start Date
2022-05-25
Trial ID
NCT05396300
Treatments Being Tested
Lung cancer is the leading cause of morbidity and mortality in the world, o...
Status
Recruiting
Location
Changzheng Hospital, Naval Military Medical University, Shanghai, China
Start Date
2025-03-24
Trial ID
NCT06903117
Treatments Being Tested
The main purpose of this research is to verify the safety of CEA targeted c...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-30
Trial ID
NCT04513431
Treatments Being Tested
This is a phase I clinical study to evaluate the safety and tolerability of...
Status
Recruiting
Location
the First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU)
Start Date
2024-07-24
Trial ID
NCT06821048
Treatments Being Tested
This is an open-label, dose-escalation, phase I trial of the safety and eff...
Status
Withdrawn
Location
Rutgers Cancer Institute of New Jersey
Start Date
2018-09-13
Trial ID
NCT03682744
Treatments Being Tested
Recurrence of liver metastasis in colorectal cancer after R0 resection is m...
Status
Recruiting
Location
Department of Colorectal Surgery in Changhai Hospital
Start Date
2022-08-25
Trial ID
NCT05240950
Treatments Being Tested